Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 7.71 Delayed Data As of 3:59pm ET |  -0.18 / -2.28%Today’s Change | 7.23 Today|||52-Week Range 10.50 | -3.75% Year-to-Date |
Latest TEVA News | Press Releases
| 2 Biotech Stocks That Could Soar in the Third Quarter Jul 02 / MotleyFool.com - Paid Partner Content | AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention Jun 22 / Zacks.com - Paid Partner Content |
| 2 Buffett Stocks That Outperformed the S&P During the Great Recession Jun 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 7.89 |
| Today’s open | 7.73 |
| Day’s range | 7.55 - 7.76 |
| Volume | 7,612,057 |
| Average volume (3 months) | 9,668,878 |
| Market cap | $8.8B |
Data as of 3:59pm ET, 07/05/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -3.84% |
| Earnings growth (next 5 years) | +1.70% |
| Revenue growth (last year) | -4.87% |
| P/E ratio | NM |
| Price/Sales | 0.56 |
| Price/Book | 0.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | +0.85 | +8.57% |
| BGNEBeigene Ltd | +27.30 | +16.34% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
Data as of 4:00pm ET, 07/05/2022
Financials
| Next reporting date | July 27, 2022 |
| EPS forecast (this quarter) | $0.56 |
| Annual revenue (last year) | $15.8B |
| Annual profit (last year) | $417.0M |
| Net profit margin | 2.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
